According to a new report Global Bioabsorbable Stents Market, published by KBV research, The Global Bioabsorbable Stents Market size is expected to reach $429.2 Million by 2027, rising at a market growth of 6.9% CAGR during the forecast period.
On the basis of biomaterial, the polymeric stents segment acquired the largest revenue share of the global bioabsorbable stents market in 2020 and would exhibit a similar trend even throughout the forecast period. Factors such as the surging utilization of polymeric stents by several companies, physicians, and patients due to less inflammatory response, complete drug elution, and less risk of related complications are responsible for the massive revenue share of this segment.
There are constant research and developmental activities witnessed in the domain of polymeric stent materials with an aim to develop innovative bioabsorbable stents, which have less risk for restenosis and late stent thrombosis.
The Coronary Artery Disease market dominated the Global Bioabsorbable Stents Market by Application in 2020. Though, the peripheral artery disease segment would showcase a promising growth rate throughout the forecast period, owing to the increasing aging population and surge in the rate of cardiac diseases.
On the basis of region, North America emerged as the leading region of the global bioabsorbable stents market and would showcase a similar trend even during the forecast period. This is credited to the surge in the occurrence of cardiovascular disease, the existence of advanced healthcare infrastructure, the surge in the number of approvals for unique bioabsorbable stents, and the existence of various leading market players.
Moreover, the growth of the regional market would be fueled by the rising cases of coronary artery disease, a surge in the coronary artery disease patient pool in hospitals, an increasing number of research and development activities in the healthcare industry, and the development of healthcare infrastructure and the existence of key players working the region.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
Global Bioabsorbable Stents Market Segmentation
- Coronary Artery Disease
- Peripheral Artery Disease
By End User
- Cardiac Center
- Rest of North America
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- Arterius Ltd.
- Elixir Medical Corporation
- Amaranth Medical, Inc.
- REVA Medical, LLC